Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-Small-Cell Lung Cancer

BACKGROUND: A trial of neoadjuvant gemcitabine and pemetrexed (GP) chemotherapy in patients with resectable non-small cell lung cancer was conducted. The goal was to achieve a disease response rate of 50% and to determine if the expression levels of genes associated with gemcitabine and pemetrexed m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bepler, Gerold, Sommers, K. Eric, Cantor, Alan, Li, Xueli, Sharma, Anupama, Williams, Charles, Chiappori, Alberto, Haura, Eric, Antonia, Scott, Tanvetyanon, Tawee, Simon, George, Obasaju, Coleman, Robinson, Lary A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2639211/
https://ncbi.nlm.nih.gov/pubmed/18827606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e3181874936
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados